TAG:
sequencing technologies
Roche Offers $5.7 Billion To Acquire Illumina Inc.
By Joseph Burns | From the Volume XIX No. 2 – January 30, 2012 Issue
CEO SUMMARY: Once again, Roche is hunting for gene sequencing and gene analysis technology that can support its goal of being a world leader in gene-based therapeutics and clinical lab testing that utilizes gene tests and molecular diagnostics. Last week, Roche launched a hostile stock te…
Whole Genome Sequencing: Is It Ready for Prime Time?
By Robert Michel | From the Volume XVII No. 16 – November 15, 2010 Issue
CEO Summary: Pathologists at Beth Israel Deaconess Medical Center in Boston, Massachusetts, in a collaboration with GenomeQuest, Inc., will produce whole human genome sequences of patient tumors and other specimens. These whole genome sequences will be studied to learn what diagn…
June 21, 2010 “Intelligence: Late Breaking Lab News”
By Robert Michel | From the Volume XVII No. 9 – June 21, 2010 Issue
Early in June, exactly 96 customers of 23andMe, Inc., were notified that they had received the wrong genetic test results. It was particularly bad timing, since the company had just been sent a letter from the FDA asserting its authority to regulate genetic testing. Bloggers reported…
Rapid Genome Sequencing Predicted by Mid-2009
By Robert Michel | From the Volume XV No. 14 – October 20, 2008 Issue
CEO SUMMARY: In the same way that the Human Genome Project was disrupted by the entry of C. Craig Venter and Perkin-Elmer in what was then a 15-year, $3 billion project, now Complete Genetics of Mountain View, California, is disrupting the race to the $1,000 human genome sequence. Develop…
July 28, 2008 “Intelligence: Late Breaking Lab News”
By Robert Michel | From the Volume XV No. 10 – July 28, 2008 Issue
Last Monday, UroPath, Inc., an Arlington, Texas, company operating anatomic pathology laboratory condominium complexes in several states, disclosed its sale to HealthTronics, Inc., of Austin, Texas. Sales price was $7.75 million. UroPath’s former owners are urologi…
June 16, 2008 “Intelligence: Late Breaking Lab News”
By Robert Michel | From the Volume XV No. 8 – June 16, 2008 Issue
GE Healthcare’s digital pathology joint venture with the University of Pittsburgh Medical Center (UPMC), announced on June 5, is not the only in vitro diagnostics (IVD) investment by GE during 2008. Just this May, GE paid $738 million to acquire …
Complete Human DNA Profiling as a STAT Test
By R. Lewis Dark | From the Volume XIII No. 2 – February 6, 2006 Issue
MOST OF YOU ARE UNFAMILIAR WITH A NEW SCIENTIFIC PRIZE that is in the planning stage. On January 27, The Wall Street Journal published a story that disclosed the plans of the X Prize Foundation to award a prize, totaling between $5 million and $20 million, to the team that first deco…
How Much Laboratory Business Intelligence Have You Missed?
Lab leaders rely on THE DARK REPORT for actionable intelligence on important developments in the business of laboratory testing. Maximize the money you make-and the money you keep! Best of all, it is released every three weeks!
Sign up for TDR Insider
Join the Dark Intelligence Group FREE and get TDR Insider FREE!
Never miss a single update on the issues that matter to you and your business.
Topics
- Anatomic Pathology
- Clinical Chemistry
- Clinical Laboratory
- Clinical Laboratory Trends
- Digital Pathology
- Genetic Testing
- In Vitro Diagnostics
- IVD/Lab Informatics
- Lab Intelligence
- Lab Marketplace
- Lab Risk & Compliance
- Laboratory Automation
- Laboratory Billing
- Laboratory Compliance
- Laboratory Equipment
- Laboratory Information Systems
- Laboratory Management
- Lean Six Sigma
- Managed Care Contracts
- Molecular Diagnostics
- Pathology Trends
- People
- Uncategorized